These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 24954505)

  • 1. The DEK oncogene promotes cellular proliferation through paracrine Wnt signaling in Ron receptor-positive breast cancers.
    Privette Vinnedge LM; Benight NM; Wagh PK; Pease NA; Nashu MA; Serrano-Lopez J; Adams AK; Cancelas JA; Waltz SE; Wells SI
    Oncogene; 2015 Apr; 34(18):2325-36. PubMed ID: 24954505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The human DEK oncogene stimulates β-catenin signaling, invasion and mammosphere formation in breast cancer.
    Privette Vinnedge LM; McClaine R; Wagh PK; Wikenheiser-Brokamp KA; Waltz SE; Wells SI
    Oncogene; 2011 Jun; 30(24):2741-52. PubMed ID: 21317931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NMR-based metabolomic analysis identifies RON-DEK-β-catenin dependent metabolic pathways and a gene signature that stratifies breast cancer patient survival.
    Vicente-Muñoz S; Hunt BG; Lange TE; Wells SI; Waltz SE
    PLoS One; 2022; 17(9):e0274128. PubMed ID: 36067206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The DEK oncogene is a target of steroid hormone receptor signaling in breast cancer.
    Privette Vinnedge LM; Ho SM; Wikenheiser-Brokamp KA; Wells SI
    PLoS One; 2012; 7(10):e46985. PubMed ID: 23071688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D3-dependent VDR signaling delays ron-mediated breast tumorigenesis through suppression of β-catenin activity.
    Johnson AL; Zinser GM; Waltz SE
    Oncotarget; 2015 Jun; 6(18):16304-20. PubMed ID: 26008979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RON and RONΔ160 promote gastric cancer cell proliferation, migration, and adaption to hypoxia via interaction with β-catenin.
    Zhou D; Huang L; Zhou Y; Wei T; Yang L; Li C
    Aging (Albany NY); 2019 May; 11(9):2735-2748. PubMed ID: 31085796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The DEK oncogene activates VEGF expression and promotes tumor angiogenesis and growth in HIF-1α-dependent and -independent manners.
    Zhang Y; Liu J; Wang S; Luo X; Li Y; Lv Z; Zhu J; Lin J; Ding L; Ye Q
    Oncotarget; 2016 Apr; 7(17):23740-56. PubMed ID: 26988756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DEK promotes HPV-positive and -negative head and neck cancer cell proliferation.
    Adams AK; Hallenbeck GE; Casper KA; Patil YJ; Wilson KM; Kimple RJ; Lambert PF; Witte DP; Xiao W; Gillison ML; Wikenheiser-Brokamp KA; Wise-Draper TM; Wells SI
    Oncogene; 2015 Feb; 34(7):868-77. PubMed ID: 24608431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. β-Catenin is required for Ron receptor-induced mammary tumorigenesis.
    Wagh PK; Gray JK; Zinser GM; Vasiliauskas J; James L; Monga SP; Waltz SE
    Oncogene; 2011 Aug; 30(34):3694-704. PubMed ID: 21423209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DEK promotes the proliferation and invasion of lung cancers and indicates poor prognosis in lung adenocarcinomas.
    Yang MQ; Bai LL; Lei L; Zheng YW; Wang Z; Li ZH; Liu CC; Huang WJ; Xu HT
    Oncol Rep; 2020 Apr; 43(4):1338-1348. PubMed ID: 32020224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silencing DEK downregulates cervical cancer tumorigenesis and metastasis via the DEK/p-Ser9-GSK-3β/p-Tyr216-GSK-3β/β-catenin axis.
    Xu X; Zou L; Yao Q; Zhang Y; Gan L; Tang L
    Oncol Rep; 2017 Aug; 38(2):1035-1042. PubMed ID: 28627610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GPNMB augments Wnt-1 mediated breast tumor initiation and growth by enhancing PI3K/AKT/mTOR pathway signaling and β-catenin activity.
    Maric G; Annis MG; MacDonald PA; Russo C; Perkins D; Siwak DR; Mills GB; Siegel PM
    Oncogene; 2019 Jun; 38(26):5294-5307. PubMed ID: 30914799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recepteur d'origine nantais tyrosine kinase is a direct target of hypoxia-inducible factor-1alpha-mediated invasion of breast carcinoma cells.
    Thangasamy A; Rogge J; Ammanamanchi S
    J Biol Chem; 2009 May; 284(21):14001-10. PubMed ID: 19307182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conditional deletion of β-catenin in mammary epithelial cells of Ron receptor, Mst1r, overexpressing mice alters mammary tumorigenesis.
    Wagh PK; Zinser GM; Gray JK; Shrestha A; Waltz SE
    Endocrinology; 2012 Jun; 153(6):2735-46. PubMed ID: 22474186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DEK proto-oncogene expression interferes with the normal epithelial differentiation program.
    Wise-Draper TM; Morreale RJ; Morris TA; Mintz-Cole RA; Hoskins EE; Balsitis SJ; Husseinzadeh N; Witte DP; Wikenheiser-Brokamp KA; Lambert PF; Wells SI
    Am J Pathol; 2009 Jan; 174(1):71-81. PubMed ID: 19036808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD36 upregulates DEK transcription and promotes cell migration and invasion via GSK-3β/β-catenin-mediated epithelial-to-mesenchymal transition in gastric cancer.
    Wang J; Wen T; Li Z; Che X; Gong L; Jiao Z; Qu X; Liu Y
    Aging (Albany NY); 2020 Nov; 13(2):1883-1897. PubMed ID: 33232276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-181-5p attenuates neutrophilic inflammation in asthma by targeting DEK.
    Song Y; Wang Z; Jiang J; Piao Y; Bai Q; Piao Q; Li L; Xu C; Liu H; Piao H; Li L; Yan G
    Int Immunopharmacol; 2022 Nov; 112():109243. PubMed ID: 36115279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The MSP-RON axis stimulates cancer cell growth in models of triple negative breast cancer.
    Millar R; Kilbey A; Remak SJ; Severson TM; Dhayade S; Sandilands E; Foster K; Bryant DM; Blyth K; Coffelt SB
    Mol Oncol; 2020 Aug; 14(8):1868-1880. PubMed ID: 32484599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical role of DEK and its regulation in tumorigenesis and metastasis of hepatocellular carcinoma.
    Yu L; Huang X; Zhang W; Zhao H; Wu G; Lv F; Shi L; Teng Y
    Oncotarget; 2016 May; 7(18):26844-55. PubMed ID: 27057626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IRAK1 is a novel DEK transcriptional target and is essential for head and neck cancer cell survival.
    Adams AK; Bolanos LC; Dexheimer PJ; Karns RA; Aronow BJ; Komurov K; Jegga AG; Casper KA; Patil YJ; Wilson KM; Starczynowski DT; Wells SI
    Oncotarget; 2015 Dec; 6(41):43395-407. PubMed ID: 26527316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.